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To the Editor: Pregnancy has long been recognised as a risk factor 
for both pandemic and seasonal influenza. Changes in the immune, 
cardiac and respiratory systems increase the risk of complications, as 
evidenced by higher hospitalisation and mortality rates in pregnant 
women during influenza outbreaks. The 2009 H1N1 pandemic was 
no exception.1 In South Africa, the high burden of HIV infection is 
a further complication. In an interim report of pH1N1-associated 
deaths in 2009, 25 (28%) of 88 deaths occurred in pregnant or 
puerperal women – 18 of 21 of these where data were known, 
occurred in the third trimester.  In 14 of these women where HIV 
status was known, 10 were HIV-positive and 4 of the 21 had active 
pulmonary TB.2
Further information on pH1N1 in pregnancy in South Africa 
was provided from an analysis of 11 deaths reported to the National 
Committee on Confidential Enquiries into Maternal Deaths in 
South Africa between July and September 2009.3 One woman was 
primigravid, and the mean gestational age was 31 (range 22 - 38) 
weeks; 9 cases were in the third trimester of pregnancy. Four or 5 
cases had underlying anaemia, 2 were diabetic and 1 was asthmatic. 
Four of the 8 patients who were HIV-tested were positive, and all 
4 had CD4 counts ≤200 cells/µl. None of the HIV-infected women 
was on antiretroviral therapy. Seven cases required ventilation. 
Most cases presented with cough, fever, diarrhoea, muscle aches 
and breathlessness, and had symptoms for 3 - 4 days before seeking 
medical attention. In some, severe illness (pneumonia and respiratory 
distress syndrome) developed very rapidly. Laboratory tests for H1N1 
were not performed on admission to hospitals because H1N1 was not 
initially considered.
It is now universally accepted that pregnancy, with or without 
additional complications, constitutes a high-risk condition for 
complications of influenza infection and warrants early intervention 
with neuraminidase inhibitors such as oseltamivir, if influenza is 
suspected (Table I). Treatment should not be delayed for laboratory 
confirmation. Although not ideal, delayed administration (over 
48 hours) could still reduce maternal morbidity and mortality. 
The regular dose of oseltamivir is 75 mg bd for 5 days; however, if 
circumstances warrant it, a higher dose of 150 mg bd for a longer 
period may be necessary. Laboratory confirmation is by PCR; 
presently available point-of-care tests such as antigen detection 
are inadequately sensitive and should not be relied on to confirm 
diagnosis. Caesarean section does not appear to improve maternal 
outcome4 and is not recommended. However, early delivery in the 
third trimester may be necessary if the patient requires mechanical 
ventilation.
In very ill patients, respiratory ventilation may be required. In our 
case series, 3 of the 11 patients required assisted respiration in an 
ICU. Patients with severe symptoms should have oxygen saturation 
monitoring and arterial blood gases performed. Antipyretics such as 
paracetamol are recommended to reduce fever in the first trimester as 
hyperpyrexia in early pregnancy has been associated with congenital 
abnormalities such as neural tube defects, cleft palate and congenital 
heart defects.4
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Pregnancy, with or without additional complications, constitutes 
a high-risk condition for complications of influenza infection and 
warrants early intervention with neuraminidase inhibitors such 
as oseltamivir, if influenza is suspected. Treatment should not be 
delayed for laboratory confirmation. In South Africa, the high 
burden of HIV infection is a further complication.
S Afr Med J 2011;110:744.
Table I. Clinical symptoms and signs warranting careful atten-
tion in pregnant women with influenza-like symptoms
Fever >39o
Diarrhoea and vomiting
Breathlessness
Underlying chronic conditions with above symptoms:
•   Anaemia
•   Asthma
•   Diabetes 
•   HIV
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